BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21753180)

  • 21. Complement membrane attack complex is related with immune-mediated necrotizing myopathy.
    Cong L; Pu CQ; Shi Q; Wang Q; Lu XH
    Int J Clin Exp Pathol; 2014; 7(7):4143-9. PubMed ID: 25120794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle and nerve involvement in granulomatous mycosis fungoides.
    Hazrati LN; Bril V; Nag S
    Muscle Nerve; 2007 Dec; 36(6):860-5. PubMed ID: 17487868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polysaccharide storage myopathy--case report and literature review.
    Miladi MI; Feki I; Choyakh F; Ben Hmida M; Zouari N; Mhiri C
    Clin Neuropathol; 2005; 24(3):126-32. PubMed ID: 15943164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-linked vacuolated myopathy: membrane attack complex deposition on the surface membrane of injured muscle fibers is not accompanied by S-protein.
    Louboutin JP; Navenot JM; Villanova M; Rouger K; Merlini L; Fardeau M
    Muscle Nerve; 1998 Jul; 21(7):932-5. PubMed ID: 9626253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Common pathological processes in somatic muscles during genetically determined metabolic myopathy in W/SSM rats].
    Nepomniashchikh LM; Bakarev MA; Tsimmerman VG
    Biull Eksp Biol Med; 1998 Aug; 126(8):228-33. PubMed ID: 9777244
    [No Abstract]   [Full Text] [Related]  

  • 26. The immunopathogenic role of complement in human muscle disease.
    Mendell JR; Garcha TS; Kissel JT
    Curr Opin Neurol; 1996 Jun; 9(3):226-34. PubMed ID: 8839617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.
    Heydemann A; McNally EM
    Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM).
    Rojana-udomsart A; Mitrpant C; Bundell C; Price L; Luo YB; Fabian V; Wilton SD; Hollingsworth P; Mastaglia FL
    J Neuroimmunol; 2013 Nov; 264(1-2):65-70. PubMed ID: 24041831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autophagic vacuolar myopathy in twin girls.
    Holton JL; Beesley C; Jackson M; Venner K; Bhardwaj N; Winchester B; Al-Memar A
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):253-9. PubMed ID: 16640643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle carnitine deficiency: adult onset lipid storage myopathy with sensory neuropathy.
    Zhang W; Miao J; Zhang G; Liu R; Zhang D; Wan Q; Yu Y; Zhao G; Li Z
    Neurol Sci; 2010 Feb; 31(1):61-4. PubMed ID: 19768376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular distribution of proteolytic enzymes in the skeletal muscle of sarcoid myopathy.
    Kumamoto T; Yukishige K; Ito T; Nagao S; Mori T; Ueyama H; Tsumura H; Tsuda T
    Acta Neuropathol; 2002 Jul; 104(1):38-44. PubMed ID: 12070662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic significance of membrane attack complex and vitronectin in childhood dermatomyositis.
    Sakuta R; Murakami N; Jin Y; Nagai T; Nonaka I; Nishino I
    J Child Neurol; 2005 Jul; 20(7):597-602. PubMed ID: 16159528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle and peripheral nerve changes caused by chronic arterial insufficiency--significance and clinical correlations--histological, histochemical and ultrastructural study.
    Farinon AM; Marbini A; Gemignani F; Govoni E; Bragaglia MM; Sianesi M; Tedeschi F
    Clin Neuropathol; 1984; 3(6):240-52. PubMed ID: 6097384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myopathy with hexagonally cross-linked crystalloid inclusions: delineation of a clinico-pathological entity.
    Claeys KG; Pellissier JF; Garcia-Bragado F; Weis J; Urtizberea A; Poza JJ; Cobo AM; Stoltenburg G; Figarella-Branger D; Willems PJ; Depuydt CE; Kleiner W; Pouget J; Piraud M; Brochier G; Romero NB; Fardeau M; Goebel HH; Bönnemann CG; Voit T; Eymard B; Laforêt P
    Neuromuscul Disord; 2010 Nov; 20(11):701-8. PubMed ID: 20637616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hindlimb ischemia-reperfusion increases complement deposition and glycolysis.
    Wong MS; Lara TM; Kobzik L; Rounds JD; Robinson MK; Jacobs DO
    J Surg Res; 1999 Jul; 85(1):130-5. PubMed ID: 10383849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle cell MHC I expression: implications for statin-induced myopathy.
    Singh P; Kohr D; Kaps M; Blaes F
    Muscle Nerve; 2010 Feb; 41(2):179-84. PubMed ID: 19813190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myocyte sarcolemmal and cytoskeleton proteins in inherited muscular diseases].
    Carpén O
    Duodecim; 2003; 119(3):179-86. PubMed ID: 12650015
    [No Abstract]   [Full Text] [Related]  

  • 38. [Peripheral neuropathy in two children with mitochondrial encephalomyopathy].
    Tanaka J; Taniike M; Inui K; Nagai T; Okada S
    Rinsho Shinkeigaku; 1991 Jul; 31(7):772-4. PubMed ID: 1664789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two related Dutch families with a clinically variable presentation of cardioskeletal myopathy caused by a novel S13F mutation in the desmin gene.
    Bergman JE; Veenstra-Knol HE; van Essen AJ; van Ravenswaaij CM; den Dunnen WF; van den Wijngaard A; van Tintelen JP
    Eur J Med Genet; 2007; 50(5):355-66. PubMed ID: 17720647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uremic myopathy.
    Campistol JM
    Kidney Int; 2002 Nov; 62(5):1901-13. PubMed ID: 12371997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.